The study, led by Patrick Singleton, PhD, adds evidence that mu opioid receptors in cancer cells influence cancer progression and spread. These receptors could become a therapeutic target for cancer treatment.
Dr. Singleton’s findings also could influence surgical anesthesia used during cancer surgery.
More Articles on Anesthesia:
Attention Anesthesiologists: CMS Guidelines on Signatures and Check Boxes
Anesthesia Machine Sales Expected to Pick Up in 2014
Heritage Valley Names Dr. Brett Anderson Chair of Anesthesiology
